Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Endovia Health SciencesEDVA +3.56%20 Debt-to-EBITDA is -0.91 as of Jun. 2026. GuruFocus rates EDVA with a GF Score™ of 20/100. The stock has 8 warning signs investors should review. Among 157 Beverages - Alcoholic companies, Endovia Health Sciences ranks worse than 636942.04% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Endovia Health Sciences's Debt-to-EBITDA or its related term are showing as below:
EDVA'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.25 Med: -0.29 Max: 8.83
Current: -0.47
During the past 13 years, the highest Debt-to-EBITDA Ratio of Endovia Health Sciences was 8.83. The lowest was -1.25. And the median was -0.29.
EDVA's Debt-to-EBITDA is ranked worse than 100% of 157
companies
in the Beverages - Alcoholic industry
Industry Median: 2.18
vs EDVA: -0.47
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Endovia Health Sciences Debt-to-EBITDA Related Terms
Endovia Health Sciences Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Beverages - Wineries & Distilleries subindustry, Endovia Health Sciences's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Endovia Health Sciences Debt-to-EBITDA vs Beverages - Alcoholic Industry
For the Beverages - Alcoholic industry and Consumer Defensive sector, Endovia Health Sciences's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Endovia Health Sciences's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Endovia Health Sciences (EDVA) has a Debt-to-EBITDA of -0.91 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Endovia Health Sciences. According to the industry distribution chart, Endovia Health Sciences ranks #999999 out of 157 companies in the Beverages - Alcoholic industry.
Is Endovia Health Sciences' Debt-to-EBITDA too high?
Endovia Health Sciences' current Debt-to-EBITDA is -0.91. Based on the distribution chart, Endovia Health Sciences ranks #999999 out of 157 companies in the Beverages - Alcoholic industry, which is in the bottom quartile relative to peers. Overall, Endovia Health Sciences has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Endovia Health Sciences' Debt-to-EBITDA compare to YHC and IBG?
According to the Beverages - Alcoholic industry distribution chart, Endovia Health Sciences ranks #999999 out of 157 companies for Debt-to-EBITDA. This places Endovia Health Sciences in the lower half of its industry. The industry median Debt-to-EBITDA is 2.18. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Beverages - Alcoholic company?
The median Debt-to-EBITDA among Beverages - Alcoholic companies is 2.18, based on 157 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Endovia Health Sciences. For the Beverages - Alcoholic industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Endovia Health Sciences's current Debt-to-EBITDA is -0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endovia Health Sciences stock overvalued right now?
Endovia Health Sciences (EDVA) has a current Debt-to-EBITDA of -0.91. The current Debt-to-EBITDA is -0.91. Endovia Health Sciences' overall GF Score™ is 20/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Endovia Health Sciences (EDVA), the current Debt-to-EBITDA is -0.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Splash Beverage Group Inc is a portfolio company managing multiple brands across several growth segments within the consumer beverage industry. The company's two reportable operating segments are: (1) the manufacture and distribution of non-alcoholic and alcoholic beverages, and (2) the retail sale of beverages and groceries online. The company generates the majority of its revenue from the E-Commerce.
20GF Score
Get the complete analysis for EDVA
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EDVA has been successfully added to your 
